Cataya
Cataya Bio | A global partner in bio-engineered excellence
Shanghai, China · Founded 2021 · $34.5M raised
- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- cataya.com
- Total Funding
- $34.5M
- Last Round
- $34.5M Venture RoundJan 2026
- Rounds
- 3
About
Cataya Bio is a synthetic biology company focused on biomanufacturing of chemical and biochemical products.
Summary
Cataya is a Biotech company based in Shanghai, China, founded in 2021. It has raised $34.5M in total across 3 rounds, most recently a $34.5M Venture Round round in Jan 2026. Investors include Hengxu Capital, Eight Roads Ventures and Bits x Bites.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.